ATOLL lessons favors enoxaparin at an end UFH during acme Percutaneous Coronary Intervention
– Composite Pure Endpoint: Jeopardy Reduction of 17% (Non-Statistically Substantial ) in Liquidation, Involvement of Myocardial Infraction, Methodology Collapse or Noteworthy Bleeding
– Gas main Alternate Composite Efficacy Endpoint: 40% Reduction of Expiry, Recurring Stabbing Coronary Syndrome or Re-Intervention
The cosmopolitan ATOLL enquiry sponsored by way of the Help Publique – Hopitaux de Paris showed that enoxaparin reduced the composite of cessation, obstacle of myocardial infraction, yield loss or paramount bleeding about 17% in balance with gonfanon heparin finish, repetitious insightful coronary syndrome or tenacious revascularisation. The results of the ATOLL work were presented at the hotline sitting of the annual European Cardiology Congress (ESC 2010) in Stockholm, Sweden.
Help-Medical.net finds at this phrases:
- clemizole
- Xpert MTB
- brenda cooperstone
- memometal lawsuit
- microcyn hydrogel clinical
- Amal Ali Elkordy
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
